Daniel E. Troy

Daniel E. Troy is the Chief Business Officer, Chief Administrative Officer, and General Counsel of Valo Health in Boston, Massachusetts. Prior to joining Valo, he served as the Senior Vice President & General Counsel of GlaxoSmithKline and was a member of its Corporate Executive Team. Before joining GSK, he was a Partner at the Washington law firm Sidley Austin LLP, where he principally represented pharmaceutical companies and trade associations on matters related to the US Food and Drug Administration (FDA) and government regulations. Dan was formerly Chief Counsel for the FDA, where he served as a primary liaison to the White House and the US Department of Health and Human Services. Dan has chaired the American Bar Association’s Section of Administrative Law, and is a member of the American Law Institute and chair of the US Chamber of Commerce Litigation Center. He has also chaired the Civil Justice Reform Group, as well as the PhRMA Law Section Executive Committee. Dan holds a B.S. in Industrial and Labor Relations from Cornell University and a J.D. from Columbia University School of Law. After graduation from law school, he was a law clerk for the U.S. Circuit Court of Appeals for the District of Columbia.